Iridex Corp (IRIX) is a publicly traded Healthcare sector company. As of July 21, 2026, IRIX trades at $0.94 with a market cap of $16.26M and a P/E ratio of 0.00. IRIX moved +0.00% today. Year to date, IRIX is -19.51%; over the trailing twelve months it is -26.54%. Its 52-week range spans $0.78 to $1.95. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces IRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for IRIX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.94 |
| Market Cap | $16.26M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.95 |
| 52-Week Low | $0.78 |
| Volume | 16.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover IRIX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.